首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Compare the safety and efficacy of intravenous iron supplementation with iron sucrose to the oral supplementation with ferrous ascorbate in subjects with post-partum anemia
【24h】

Compare the safety and efficacy of intravenous iron supplementation with iron sucrose to the oral supplementation with ferrous ascorbate in subjects with post-partum anemia

机译:比较在产后贫血患者中静脉内补充蔗糖铁与口服抗坏血酸亚铁的安全性和有效性

获取原文
           

摘要

Background: The post-partum period is challenging enough for most new mothers. Recovering from birth, learning to parent, and taking care of her child requires lot of energy. Having anemia in postpartum period can make this process much more difficult. According to WHO, in India incidence of anemia in postnatal mother is around 58% and according to ICMR prevalence of anemia in Tamil Nadu population 76% during pregnancy. The objective of this study was to compare the efficacy of intravenous iron supplementation with Iron sucrose to the oral supplementation with ferrous ascorbate in management of patient with post-partum anemia. To study the safety and side effects of these two preparations. Methods: This was a prospective study conducted on 100 post-partum anemic women in KG Hospital in Coimbatore, October 2012 to November 2013 with hemoglobin less than 10g/dl but more than 6g/dl within 24-48 hours of delivery ,after satisfying inclusion and exclusion criteria were included in the study. Results: Mean hemoglobin of oral group was 8.49±0.75 and mean hemoglobin of IV group was 8.43±0.76; 24 hours after delivery. After treatment, that is after 4 weeks mean hemoglobin of oral group was 10.38±0.79 and mean hemoglobin of IV group was 11.20±0.71.on comparing both groups, the increase in hemoglobin in the IV groups was significant. Reticulocyte count and other parameters increased significantly after four wks of starting therapy in IV group compare to the oral group. No major side effects or anaphylactic reactions were noted during study period. Conclusions: Intravenous iron sucrose complex is safe, convenient and effective in postpartum anemic women as compared with the oral ferrous ascorbate. Intravenous iron sucrose have shorter treatment periods, increased likelihood of compliance, a lack of gastrointestinal side effects, and rapid replenishment of iron stores, making them superior to oral ferrous ascorbate.
机译:背景:对于大多数新妈妈来说,产后时期都充满了挑战。从出生中恢复健康,学习父母生活以及照顾孩子需要大量的精力。产后贫血会使这一过程更加困难。根据世界卫生组织的数据,印度产后母亲的贫血发生率约为58%,而根据ICMR的数据,泰米尔纳德邦怀孕期间的贫血患病率为76%。本研究的目的是比较蔗糖铁静脉补充铁剂与口服抗坏血酸亚铁补充剂治疗产后贫血的疗效。研究这两种制剂的安全性和副作用。方法:这是一项前瞻性研究,于2012年10月至2013年11月在哥印拜陀的KG医院对100名产后贫血妇女进行,在分娩后24-48小时内血红蛋白低于10g / dl但高于6g / dl排除标准已纳入研究。结果:口服组平均血红蛋白为8.49±0.75,静脉注射组平均血红蛋白为8.43±0.76。交货后24小时。治疗后4周,口服组的平均血红蛋白为10.38±0.79,IV组的平均血红蛋白为11.20±0.71。与口服组相比,IV组开始治疗四周后网织红细胞计数和其他参数显着增加。在研究期间未发现主要副作用或过敏反应。结论:与口服抗坏血酸亚铁相比,静脉内蔗糖铁复合物对产后贫血妇女安全,方便,有效。静脉内蔗糖铁的治疗时间更短,顺应性增加,没有胃肠道副作用,并且铁储备迅速补充,使其优于口服抗坏血酸亚铁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号